Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Breast Neoplasms 3 Multiple Myeloma 2 Fallopian Tube Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Platinum-resistant Recurrent Ovarian Cancer 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Ovarian Cancer Recurrent 1 Lymphoma, Follicular 1 Lymphoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Ovarian Cancer 1

Interventions

Carboplatin 2 Bevacizumab 2 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 liposomal doxorubicin 1 Saline Solution 1 Paclitaxel 1 Neoadjuvant Therapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Ovarian Cancer × 1-dodecylpyridoxal × Clear all

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡